Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Completed × Dyspnea × Clear all

Phase

Phase NA 12 Phase 2 7 Phase 2/3 2 Phase 4 1 Phase 3 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 262 Carcinoma, Non-Small-Cell Lung 216 Neoplasms 215 Leukemia, Myeloid, Acute 191 Multiple Myeloma 178 Colorectal Neoplasms 173 Prostatic Neoplasms 165 Melanoma 165 Lymphoma 143 Leukemia 142 Lymphoma, Non-Hodgkin 132 Glioblastoma 130 Pancreatic Neoplasms 127 Neoplasm Metastasis 118 Leukemia, Lymphocytic, Chronic, B-Cell 118 Lung Neoplasms 117 Ovarian Neoplasms 112 Precursor Cell Lymphoblastic Leukemia-Lymphoma 106 Recurrence 97 Myelodysplastic Syndromes 93 Hodgkin Disease 92 Lymphoma, Large B-Cell, Diffuse 89 Lymphoma, Follicular 89 Lymphoma, Mantle-Cell 83 Head and Neck Neoplasms 79 Carcinoma, Renal Cell 79 Brain Neoplasms 77 Carcinoma, Hepatocellular 73 Squamous Cell Carcinoma of Head and Neck 69 Sarcoma 68

Interventions

Surveys and Questionnaires 1 Fentanyl 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01515566 2014-08-22

Breakthrough Dyspnea Fentanyl Study in Cancer Patients

M.D. Anderson Cancer Center

Phase 1/2 Completed

26 enrolled 7 charts

Dyspnea

Data powered by HemOnc (CC BY 4.0) Colophon ⚡